↓ Skip to main content

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
8 X users
patent
1 patent

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
86 Mendeley